Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

Study Summary

This study will evaluate the effect of investigational drugs, pembrolizumab alone or pembrolizumab with lenvatinib, on the immune systems response to kidney cancer when given before and after surgery to remove kidney cancer.